IN2013MU00985A - - Google Patents

Download PDF

Info

Publication number
IN2013MU00985A
IN2013MU00985A IN985MU2013A IN2013MU00985A IN 2013MU00985 A IN2013MU00985 A IN 2013MU00985A IN 985MU2013 A IN985MU2013 A IN 985MU2013A IN 2013MU00985 A IN2013MU00985 A IN 2013MU00985A
Authority
IN
India
Prior art keywords
provides
composition
therapeutic agents
present
delivery
Prior art date
Application number
Other languages
English (en)
Inventor
Banerjee Prof Rinti
Guha Sarkar Shruti
Original Assignee
Indian Inst Technology Bombay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indian Inst Technology Bombay filed Critical Indian Inst Technology Bombay
Priority to IN985MU2013 priority Critical patent/IN2013MU00985A/en
Publication of IN2013MU00985A publication Critical patent/IN2013MU00985A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN985MU2013 2013-03-22 2013-03-22 IN2013MU00985A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN985MU2013 IN2013MU00985A (pt) 2013-03-22 2013-03-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN985MU2013 IN2013MU00985A (pt) 2013-03-22 2013-03-22

Publications (1)

Publication Number Publication Date
IN2013MU00985A true IN2013MU00985A (pt) 2015-05-29

Family

ID=54395121

Family Applications (1)

Application Number Title Priority Date Filing Date
IN985MU2013 IN2013MU00985A (pt) 2013-03-22 2013-03-22

Country Status (1)

Country Link
IN (1) IN2013MU00985A (pt)

Similar Documents

Publication Publication Date Title
PH12019502018A1 (en) Compositions, formulations and methods for treating ocular diseases
HRP20190117T1 (hr) iRNK TERAPIJA ZA LIJEČENJE BOLESTI OKA
MY189979A (en) Prodrugs of a jak inhibitor compound for treatment of gastrointestinal inflammatory disease
TW201613901A (en) New compounds
MX2021007268A (es) Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas.
PH12017500493A1 (en) Combination therapy
GT201200315A (es) Agentes inductores de apoptosis para el tratamiento del cáncer y de enfermedades inmunes y autoinmunes
EP2424360A4 (en) TOPICAL, PERIOCULAR OR INTRAOCULAR USE OF TOCOTRIENOLS FOR THE TREATMENT OF OPHTHALMIC DISEASES
GB201118656D0 (en) New compounds
MX2021008663A (es) Anticuerpos mejorados contra il-6.
CL2018000597A1 (es) Métodos para tratar enfermedades inflamatorias
MX2014005209A (es) Un medicamento para tratar la enfermedad del ojo anterior que comprende rebamipida y un agente de retencion de lagrimas.
MX2021006901A (es) Agentes terapeuticos para enfermedades neurodegenerativas.
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
MX2015006337A (es) Metodos y composiciones para tratar enfermedades neurodegenerativas.
EA201690191A1 (ru) Фармацевтическая композиция для замедленного высвобождения ланреотида
BR112017007916A2 (pt) compostos sarms para tratamento de distúrbios urológicos
PH12014502065A1 (en) Vesicular formulations
MX2020003427A (es) Agentes terapeuticos para enfermedades neurodegenerativas.
EP3310396A4 (en) THERAPEUTIC HYDROGELS BASED ON NANOFIBRES FOR THE LOCAL TREATMENT OF BRAIN DISEASES
IN2013MU00985A (pt)
NZ623275A (en) Treatment of ocular disease